Purchase Order 75N91024P00688
Award Date
9/9/24
Potential Completion Date
11/25/24
Potential Value
$89K
Federal Agency
National Cancer Institute
Awardee
Cantata Bio LLC
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Santa Cruz, CA 95066, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price BPA Call order from the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, is valued at twenty-four thousand eight hundred fifty-seven dollars and eighty-four cents ($24,857.84). Prime contractor 10X Genomics, Inc. will provide single cell kits to the Chen Lab members at its Pleasanton, California location for use in single-cell analysis and research from November 16, 2022 through December 15, 2022. ...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (NIH NCI) awarded a $162,925.72 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit organization, for the procurement of a 3-Laser Attune CytPix Cytometer with CytKickMAX premium autosampler. This specialized flow cytometer instrument will be used by the NCI's Surgery Branch Flow Cytometer core facility to support ongoing cancer research, including DNA cell cycle...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $41,280.50 firm fixed-price purchase order to Nanostring Technologies, Inc., a small business manufacturer, for NanoString CosMx Spatial Gene Expression Library Preparation Kits. This purchase order is likely related to a larger federal contract vehicle utilized by the NCI and other agencies to procure Nanostring's specialized genomic analysis platforms, assays, and related services to support...
This is a $142,990 firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract has no set-aside designation. Illumina has previously received prime federal contract awards from other agencies like the CDC, USDA, and VA to provide sequencing systems, reagents, and related services in support of genomics...
This is a $24,999.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment and reagents. The contract is for the delivery of unspecified laboratory equipment, with a period of performance through September 7, 2024. While not awarded under a set-aside program, Miltenyi Biotec has extensive...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to C S Bio Co., a Minority Owned Business, Subchapter S Corporation, for $18,175.00 in laboratory testing services. The contract has an anticipated completion date of August 31, 2024 and was awarded on April 1, 2024. The services will be performed in Bethesda, Maryland. No set-aside was used for this award.</p>
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,806.85 firm fixed price purchase order to Miltenyi Biotec, Inc. for equipment. The place of performance will be in Auburn, California, and the period of performance is from November 8, 2023 through December 26, 2023. This purchase order was awarded under the National Cancer Institute's research programs to procure equipment that will support the agency's efforts to advance cancer...
This is a firm fixed-price purchase order awarded by the U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to acquire one Incucyte SX5 Live-Cell Analysis System. The purchase order, valued at $146,718.60, was awarded to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The acquisition is for the Laboratory of Cancer Biology and Genetics within the NCI's Center for Cancer Research to...
This is a federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Pointcare Genomics Corp, a small minority-owned business, for research and development in biomedical basic research. The contract is a definitive, firm-fixed price contract valued at $299,961.00 and is part of the SBIR (Small Business Innovation Research) Program Phase I. The contract has a total small business set-aside designation and was awarded on September 22, 2015, with a completion date of...
This federal contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Cellecta, Inc., a for-profit manufacturer of genomic research products and services. The $299,952 firm-fixed price contract is for "GENETIC ANALYSIS OF CTCS AT THE SINGLE-CELL LEVEL" and does not have a set-aside designation. Cellecta specializes in providing advanced genomic technologies, including CRISPR, RNAi, and other tools, to support biomedical research...